Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
1063/15 07/09/2015 bevacizumab (Avastin) Full In combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vascular endothelial growth factor (VEGF) inhibitors or VEGF receptor-targeted agents
634/10 13/09/2010 trabectedin (Yondelis) Full Ovarian Cancer
503/08 13/07/2009 pegylated liposomal doxorubicin in combination with boretezomib (Caelyx plus Velcade) Resubmission Progressive multiple myeloma
503/08 13/10/2008 pegylated liposomal doxorubicin (Caelyx) Full Progressive multiple myeloma in patients who have received at least one prior therapy
84/03 12/01/2004 Pegylated liposomal doxorubicin (Caelyx®) Full Metastatic breast cancer

No medicines have been found.